Walleye Trading
AERI

Walleye Trading’s Aerie Pharmaceuticals AERI Stock Holding History

Walleye Trading’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-600
Closed -$5K – 5895
2022
Q1 		$5K Buy
600
+500
+500% +$3.85K ﹤0.01% 5129
2021
Q4 		$1K Hold
100
– – ﹤0.01% 5269
2021
Q3 		$1K Buy
+100
New +$1.46K ﹤0.01% 5126
2020
Q3 		– Sell
-11,200
Closed -$165K – 4795
2020
Q2 		$165K Sell
11,200
-3,300
-23% -$48.8K ﹤0.01% 3212
2020
Q1 		$196K Sell
14,500
-13,600
-48% -$258K ﹤0.01% 2613
2019
Q4 		$679K Buy
28,100
+18,200
+184% +$377K ﹤0.01% 2146
2019
Q3 		$190K Buy
9,900
+8,000
+421% +$183K ﹤0.01% 2960
2019
Q2 		$56K Buy
+1,900
New +$73.2K ﹤0.01% 3501
2018
Q4 		– Sell
-4,300
Closed -$265K – 5527
2018
Q3 		$265K Buy
4,300
+3,500
+438% +$225K ﹤0.01% 3514
2018
Q2 		$54K Sell
800
-2,200
-73% -$123K ﹤0.01% 4233
2018
Q1 		$163K Buy
3,000
+600
+25% +$33.6K ﹤0.01% 3632
2017
Q4 		$144 Buy
+2,400
New +$146K ﹤0.01% 3658

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's AERI Position: Q3 2022 in Review

Walleye Trading sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 15,894 shares — an estimated $119K sold.

Walleye Trading first reported a position in AERI in Q2 2015 and held it in 11 quarters. The position peaked at $487K in Q2 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Walleye Trading reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 15,894 Aerie Pharmaceuticals shares in Q3 2022, an estimated $119K.
  • Walleye Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Walleye Trading's Aerie Pharmaceuticals position peaked at $487K in Q2 2018.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.